SEOM-GEICO clinical guidelines on endometrial cancer (2021)

Clinical Practice
DOI: 10.1007/s12094-022-02799-7 Publication Date: 2022-03-21T15:03:42Z
ABSTRACT
Endometrial cancer (EC) is the second most common gynecological malignancy worldwide, first in developed countries [Sung et al. CA Cancer J Clin 71:209-249, 2021]. Although a majority diagnosed at an early stage with low risk of relapse, important proportion patients will relapse. Better knowledge molecular abnormalities crucial to identify high-risk groups stages as well for recurrent or metastatic disease whom adjuvant treatment must be personalized. The objective this guide summarize current evidence diagnosis, treatment, and follow-up EC, provide evidence-based recommendations clinical practice.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (48)
CITATIONS (17)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....